Skip to content

Evommune EVMN Accounts Receivable

Accounts Receivable at other companies

Pfizer logo
PfizerPFE
$12.59B+6.2%
Bausch + Lomb logo
Bausch + LombBLCO
$1.11B+9.8%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$61.31M+1,156%
Perrigo Company logo
Perrigo CompanyPRGO
$697.1M-2.7%
Hims & Hers Health logo
Hims & Hers HealthHIMS

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableGrossCurrent.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's accounts receivable?
Evommune (EVMN) reported accounts receivable of $372.71K in Q1 2026.
How has Evommune 's accounts receivable changed year-over-year?
Evommune 's accounts receivable increased by 6481.0% year-over-year, from -$5.84K to $372.71K.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.